Tempus AI Overview
- Year Founded
-
2015
- Status
-
Public
- Employees
-
2,422
- Stock Symbol
-
TEM
- Investments
-
7
- Share Price
-
$48.82
- (As of Friday Closing)
Tempus AI General Information
Description
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Contact Information
Website
www.tempus.comCorporate Office
- 600 West Chicago Avenue
- Suite 510
- Chicago, IL 60654
- United States
Corporate Office
- 600 West Chicago Avenue
- Suite 510
- Chicago, IL 60654
- United States
Tempus AI Timeline
Tempus AI Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $48.82 | $45.98 | $22.89 - $77.00 | $7.53B | 154M | 1.03M | -$11.55 |
Tempus AI Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 7,294,246 | |||
| Revenue | 595,570 | 531,822 | 320,668 | 257,853 |
| EBITDA | (638,644) | (140,929) | (239,878) | (220,146) |
| Net Income | (720,864) | (214,118) | (289,811) | (259,192) |
| Total Assets | 864,611 | 564,052 | 631,364 | 531,354 |
| Total Debt | 475,567 | 488,142 | 433,029 | 238,946 |
Tempus AI Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Tempus AI Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Tempus AI Comparisons
Industry
Financing
Details
Tempus AI Competitors (39)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Personalis | Formerly VC-backed | Fremont, CA | ||||
| GenomOncology | Venture Capital-Backed | Cleveland, OH | ||||
| Strand Life Sciences | Formerly VC-backed | Bangalore, India | ||||
| OpGen | Formerly VC-backed | Rockville, MD | ||||
| Genuity Science | Formerly VC-backed | Dublin, Ireland |
Tempus AI Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
News about Tempus AI
Dive into recent articles by PitchBook offering invaluable insights and context.
-
NEWS | Jun 13, 2024
Tempus AI prices IPO at 38% cut from valuation peak
Tempus AI came out swinging on AI in its S-1 filing, but its continued losses and a fragile IPO market complicate things.
-
NEWS | Aug 7, 2024
SoftBank still on the hunt for AI deals despite losses, market turmoil
SoftBank Group has reported gains for its investment arms as it contends with trading volatility.
Tempus AI Patents
Tempus AI Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4439579-A1 | Image viewing pipeline for medical image viewer | Pending | 27-Mar-2023 | ||
| US-20240331859-A1 | Image viewing pipeline for medical image viewer | Pending | 27-Mar-2023 | ||
| US-20240266009-A1 | Sparse n-gram modeling for patient-entity relation extraction | Pending | 02-Feb-2023 | ||
| US-20240221874-A1 | Systems and methods for predicting patient recruitment at clinical sites | Pending | 30-Dec-2022 | ||
| CA-3224951-A1 | Systems and methods for predicting patient recruitment at clinical sites | Pending | 30-Dec-2022 | G16H10/20 |
Tempus AI Executive Team (30)
| Name | Title | Board Seat |
|---|---|---|
| Jim Rogers | Chief Financial Officer | |
| Ryan Fukushima | Chief Operating Officer, Operations | |
| Shane Colley | Chief Technology Officer | |
| Mike Yasiejko | Executive Vice President & General Manager of Genomics | |
| Ryan Bartolucci | Chief Accounting Officer, Accounting |
Tempus AI Board Members (12)
| Name | Representing | Role | Since |
|---|---|---|---|
| David Epstein | Self | Board Member | |
| Eric Belcher | Self | Board Member | |
| Eric Lefkofsky JD | Self | Chief Executive Officer & Chairman | |
| Jennifer Doudna Ph.D | Self | Board Member | |
| Jennifer Doudna | Self | Board Member |
Tempus AI Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Tempus AI Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Tempus AI Investments & Acquisitions (7)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Provider of Medical Services with AI (SoftBank Group / Tempus AI) | 01-May-2024 | Database Software | |||
| Mpirik | 09-Mar-2023 | Enterprise Systems (Healthcare) | |||
| Arterys | 03-Oct-2022 | Decision/Risk Analysis | |||
| Highline Sciences | 08-Feb-2022 | Practice Management (Healthcare) | |||
| Akrivia Health | 22-Jun-2021 | Early Stage VC | Medical Records Systems |
Tempus AI Subsidiaries (2)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Arterys | Decision/Risk Analysis | San Francisco, CA | 2011 |
| Mpirik | Enterprise Systems (Healthcare) | Milwaukee, WI |
Tempus AI ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Software & Services
Industry
Rank
Percentile
Enterprise and Infrastructure Software
Subindustry
Rank
Percentile
Tempus AI FAQs
-
When was Tempus AI founded?
Tempus AI was founded in 2015.
-
Who is the founder of Tempus AI?
Eric Lefkofsky JD and Bradley Keywell JD are the founders of Tempus AI.
-
Who is the CEO of Tempus AI?
Eric Lefkofsky JD is the CEO of Tempus AI.
-
Where is Tempus AI headquartered?
Tempus AI is headquartered in Chicago, IL.
-
What is the size of Tempus AI?
Tempus AI has 2,422 total employees.
-
What industry is Tempus AI in?
Tempus AI’s primary industry is Biotechnology.
-
Is Tempus AI a private or public company?
Tempus AI is a Public company.
-
What is Tempus AI’s stock symbol?
The ticker symbol for Tempus AI is TEM.
-
What is the current stock price of Tempus AI?
As of 11-Oct-2024 the stock price of Tempus AI is $48.82.
-
What is the current market cap of Tempus AI?
The current market capitalization of Tempus AI is $7.53B.
-
What is Tempus AI’s current revenue?
The trailing twelve month revenue for Tempus AI is $596M.
-
Who are Tempus AI’s competitors?
Personalis, GenomOncology, Strand Life Sciences, OpGen, and Genuity Science are some of the 39 competitors of Tempus AI.
-
What is Tempus AI’s annual earnings per share (EPS)?
Tempus AI’s EPS for 12 months was -$11.55.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
